|
covid-19 |
12 |
|
sars-cov-2 |
12 |
|
anosmia |
9 |
|
olfactory dysfunction |
9 |
|
smell impairment |
9 |
|
acute infection |
6 |
|
convalescent |
6 |
|
dendritic cell |
6 |
|
adolescent |
2 |
|
adult |
2 |
|
attitude to health |
2 |
|
cannulation |
2 |
|
credentialing |
2 |
|
crisis resource management |
2 |
|
cross-sectional study |
2 |
|
debriefing |
2 |
|
double lumen cannula |
2 |
|
dual lumen cannula |
2 |
|
ecmo crisis |
2 |
|
extracorporeal membrane oxygenation |
2 |
|
extracorporeal membrane oxygenation (ecmo) |
2 |
|
female |
2 |
|
high-fidelity simulation |
2 |
|
human learning |
2 |
|
simulation |
2 |
|
venoarterial extracorporeal membrane oxygenation (va ecmo) |
2 |
|
aged |
1 |
|
antithrombotic agents |
1 |
|
brain ischemia |
1 |
|
cohort analysis |
1 |
|
delayed emergence from anesthesia |
1 |
|
disease association |
1 |
|
electronic health record |
1 |
|
feasibility study |
1 |
|
icu |
1 |
|
lung protection ventilation: pressure goal |
1 |
|
meta-analysis |
1 |
|
mortality |
1 |
|
neostigmine: dose rationale |
1 |
|
neuromuscular block: assessment |
1 |
|
obesity |
1 |
|
obesity paradox |
1 |
|
overweight |
1 |
|
paradoxical embolism |
1 |
|
patent foramen ovale |
1 |
|
patient care |
1 |
|
pressure‐controlled ventilation |
1 |
|
quality measures |
1 |
|
sepsis |
1 |
|
septic shock |
1 |
|
stroke |
1 |
|
surgery |
1 |
|
volume‐controlled ventilation |
1 |
